State of Wisconsin Investment Board’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

State of Wisconsin Investment Board’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,825	Closed	-$1.02M	–	2644
2022 Q4	$1.02M	Hold	100,825	–	–	﹤0.01%	1498
2022 Q3	$1M	Hold	100,825	–	–	﹤0.01%	1544
2022 Q2	$987K	Hold	100,825	–	–	﹤0.01%	1644
2022 Q1	$985K	Buy	+100,825	New	+$980K	﹤0.01%	1644

State of Wisconsin Investment Board's EBAC Position: Q1 2023 in Review

State of Wisconsin Investment Board sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 100,825 shares — an estimated $1.02M sold.

State of Wisconsin Investment Board first reported a position in EBAC in Q1 2022 and held it in 4 quarters. The position peaked at $1.02M in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

State of Wisconsin Investment Board reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
State of Wisconsin Investment Board sold 100,825 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $1.02M.
State of Wisconsin Investment Board first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 4 quarters.
State of Wisconsin Investment Board's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $1.02M in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2023, filed 15 May 2023.